Neogen Current Ratio 2006-2019 | NEOG

Neogen current ratio from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Neogen Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-02-28 $0.42B $0.03B 12.33
2018-11-30 $0.41B $0.04B 10.69
2018-08-31 $0.40B $0.04B 10.10
2018-05-31 $0.38B $0.04B 9.71
2018-02-28 $0.35B $0.04B 9.44
2017-11-30 $0.34B $0.04B 8.96
2017-08-31 $0.31B $0.04B 8.11
2017-05-31 $0.29B $0.04B 8.14
2017-02-28 $0.28B $0.04B 7.97
2016-11-30 $0.29B $0.03B 8.52
2016-08-31 $0.27B $0.03B 8.23
2016-05-31 $0.25B $0.03B 8.68
2016-02-29 $0.26B $0.03B 9.18
2015-11-30 $0.25B $0.03B 8.02
2015-08-31 $0.24B $0.03B 8.75
2015-05-31 $0.23B $0.03B 9.08
2015-02-28 $0.22B $0.03B 8.19
2014-11-30 $0.21B $0.02B 8.53
2014-08-31 $0.20B $0.02B 8.22
2014-05-31 $0.19B $0.03B 7.56
2014-02-28 $0.18B $0.03B 7.17
2013-11-30 $0.18B $0.02B 7.68
2013-08-31 $0.18B $0.02B 7.79
2013-05-31 $0.17B $0.02B 9.51
2013-02-28 $0.16B $0.02B 7.09
2012-11-30 $0.15B $0.02B 8.33
2012-08-31 $0.15B $0.02B 8.05
2012-05-31 $0.14B $0.02B 7.21
2012-02-29 $0.14B $0.02B 7.81
2011-11-30 $0.13B $0.02B 7.08
2011-08-31 $0.12B $0.02B 6.81
2011-05-31 $0.12B $0.02B 6.88
2011-02-28 $0.11B $0.02B 5.57
2010-11-30 $0.11B $0.02B 5.08
2010-08-31 $0.10B $0.02B 4.90
2010-05-31 $0.09B $0.02B 5.05
2010-02-28 $0.09B $0.02B 6.15
2009-11-30 $0.09B $0.02B 6.08
2009-08-31 $0.08B $0.01B 6.55
2009-05-31 $0.07B $0.01B 7.76
2009-02-28 $0.07B $0.01B 6.26
2008-11-30 $0.07B $0.01B 5.82
2008-08-31 $0.07B $0.01B 5.06
2008-05-31 $0.07B $0.01B 5.89
2008-02-29 $0.06B $0.01B 5.16
2007-11-30 $0.06B $0.01B 5.57
2007-08-31 $0.05B $0.01B 5.39
2007-05-31 $0.05B $0.01B 5.09
2007-02-28 $0.05B $0.01B 5.25
2006-11-30 $0.05B $0.01B 4.68
2006-08-31 $0.04B $0.01B 5.00
2006-05-31 $0.04B $0.01B 3.62
2006-02-28 $0.04B $0.01B 4.24
2005-11-30 $0.03B $0.01B 5.18
2005-08-31 $0.03B $0.01B 4.43
2005-05-31 $0.03B $0.01B 4.95
2005-02-28 $0.03B $0.01B 5.69
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.958B $0.402B
Neogen Corporation develops, manufactures and markets a diverse line of products dedicated to food and animal safety. The Company's Lansing, Mich.-based Food Safety Division develops and markets dehydrated culture media, and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases, and sanitation concerns. Neogen's is the leading global provider of DNA testing for animal agribusiness and veterinary medicine. Neogen understands that its customers face serious consequences if their products are contaminated with any of a number of well-established or emerging threats, including dangerous bacteria, natural toxins, veterinary drug residues, unlabeled food allergens, rodent filth, sanitation concerns, broken veterinary needles or other contaminants.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $129.838B 25.32
Medtronic (MDT) Ireland $112.952B 16.51
Stryker (SYK) United States $67.256B 24.66
Boston Scientific (BSX) United States $48.820B 23.72
Baxter (BAX) United States $37.991B 24.37
Zimmer Biomet Holdings (ZBH) United States $24.550B 15.71
Smith & Nephew SNATS (SNN) United Kingdom $16.615B 0.00
Canopy Growth (CGC) Canada $14.912B 0.00
ResMed (RMD) United States $14.218B 26.96
Aurora Cannabis (ACB) Canada $9.118B 64.29
Bio-Rad Laboratories (BIO) United States $8.765B 50.28
Perrigo (PRGO) Ireland $6.633B 10.75
Hill-Rom Holdings (HRC) United States $6.374B 19.72
Insulet (PODD) United States $4.900B 1642.60
GW Pharmaceuticals (GWPH) United Kingdom $4.701B 0.00
ICU Medical (ICUI) United States $4.568B 28.29
Haemonetics (HAE) United States $4.189B 37.16
Hutchison China MediTech (HCM) China $4.046B 0.00
Agios Pharmaceuticals (AGIO) United States $3.268B 0.00
NuVasive (NUVA) United States $2.784B 24.18
Quidel (QDEL) United States $2.365B 21.17
National Vision Holdings (EYE) United States $2.220B 43.66
Aphria (APHA) $1.917B 0.00
Phibro Animal Health (PAHC) United States $1.349B 19.38
VAREX IMAGING (VREX) United States $1.222B 23.93
Cardiovascular Systems (CSII) United States $1.190B 854.00
AtriCure (ATRC) United States $1.049B 0.00
Lantheus Holdings (LNTH) United States $0.931B 25.16
Omeros (OMER) United States $0.908B 0.00
PetIQ (PETQ) United States $0.862B 24.67
MacroGenics (MGNX) United States $0.791B 0.00
Cerus (CERS) United States $0.787B 0.00
NanoString Technologies (NSTG) United States $0.737B 0.00
TG Therapeutics (TGTX) United States $0.689B 0.00
Evolus (EOLS) United States $0.681B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.666B 22.66
OraSure Technologies (OSUR) United States $0.594B 25.86
Surmodics (SRDX) United States $0.546B 79.43
LeMaitre Vascular (LMAT) United States $0.536B 25.46
Meridian Bioscience (VIVO) United States $0.531B 15.82
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.88
Insys Therapeutics (INSY) United States $0.313B 0.00
BioLife Solutions (BLFS) United States $0.305B 125.85
Vapotherm (VAPO) United States $0.296B 0.00
Rockwell Medical (RMTI) United States $0.271B 0.00
Cytosorbents (CTSO) United States $0.219B 0.00
Owens & Minor (OMI) United States $0.213B 2.91
Zynex (ZYXI) United States $0.171B 18.31
Chimerix (CMRX) United States $0.133B 0.00
Bovie Medical (APYX) United States $0.131B 0.00
Fonar (FONR) United States $0.125B 6.68
Chembio Diagnostics (CEMI) United States $0.121B 0.00
Surface Oncology (SURF) United States $0.113B 0.00
Female Health (VERU) United States $0.088B 0.00
United-Guardian (UG) United States $0.088B 20.06
CAS Medical Systems (CASM) United States $0.072B 0.00
Neurotrope (NTRP) United States $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.071B 21.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
ImmuCell (ICCC) United States $0.043B 0.00
Senestech (SNES) United States $0.034B 0.00
Valeritas Holdings (VLRX) United States $0.031B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 13.71